Reviewers urge Glaxo's Avandia come off market

The Food and Drug Administration will again ask an advisory panel to consider the risks of the drug, Glaxo's second biggest-selling product before questions about a possible link to heart attacks emerged in 2007.

Reviewers urge Glaxo's Avandia come off market

Two U.S. drug safety reviewers have recommended that GlaxoSmithKline PLC's diabetes drug Avandia be pulled from the market after concluding it is more dangerous to the heart than a rival medicine, according to documents released on Saturday.

New seasonal flu vaccine to contain H1N1 strain

The composition of the vaccine, announced at the end of a closed-door four-day meeting of influenza experts that is closely followed by the world's vaccine makers, means governments that have stockpiled doses of H1N1 swine flu vaccine may now use them for part of the seasonal flu vaccine mix.

Popular antidepressant interferes with cancer drug

Women who took GlaxoSmithKline's Paxil while taking tamoxifen at the same time were more likely to die of their breast cancer, the researchers found. The longer the overlap between Paxil and tamoxifen, the more likely the patients were to die, they reported in the British Medical Journal.

Low-carb diet best for lowering blood pressure

In the study, overweight or obese individuals who went on a low-carb diet lost about the same amount of weight as those who cut down on their fat intake and took the weight-loss aid orlistat (sold as Xenical or Alli). However, the low-carb diet produced more favorable effects on blood pressure.

No U.S. decision on H1N1 vaccine orders - official

The United States has made no decision on whether to cancel or sell any of its orders for the H1N1 vaccine, unlike some European countries with a vast oversupply of shots, a federal health official said on Thursday.

Swine flu deadlier in children than seasonal flu

H1N1 swine flu can kill children at a much higher rate than seasonal flu, and the elevated risk for pregnant women extends as long as two weeks after they give birth, researchers reported on Wednesday.

Glaxo boosts consumer health with cold sore deal

GlaxoSmithKline (GSK.L) took a further step to build up its non-prescription consumer health business on Wednesday with a small deal giving it rights to an experimental cold sore treatment from privately owned NanoBio.

EU: no safety concerns as 10 million get H1N1 shots

Some 10 million people across the European Union have now been vaccinated against H1N1 swine flu and so far no unexpected serious safety issues have been identified, the region's drugs watchdog said on Thursday.

Sanofi lifts forecast on swine flu vaccine

Sanofi-Aventis raised its outlook for 2009 thanks to sales of swine flu vaccine and posted earnings per share growth that beat forecasts as competition from generics was offset by revenue growth for other drugs.


IBTimes Logo

Glaxo gives price pledge as malaria shot holds hope

More than 5,500 children across Africa have been given an experimental new malaria vaccine and the British drugmaker behind it, GlaxoSmithKline, promised on Wednesday that price would be no hurdle if it works.
IBTimes Logo

New flu can kill fast, researchers agree

The new H1N1 flu is strikingly different from seasonal influenza, killing much younger people than ordinary flu and often killing them very fast, World Health Organization officials said on Friday.
IBTimes Logo

Roche benefits from Tamiflu sales as Q3 shines

Roche's third-quarter sales rose 10 percent to 12.4 billion Swiss francs ($12.2 billion), helped by its cancer drugs and increased demand for flu medicine Tamiflu due to the H1N1 pandemic.
IBTimes Logo

Roche sales beat forecasts, ups Tamiflu guidance

Roche's third-quarter sales rose 14 percent to 12.4 billion Swiss francs ($12.2 billion), helped by its cancer drugs and beating expectations, and it upped its forecast for flu medicine Tamiflu.